Immunotherapy for pancreatic cancer boosts survival more than 75 percent in mice, study finds

$ 13.00

4.8
(567)
In stock
Description

Dilemma and Challenge of Immunotherapy for Pancreatic Cancer

Internal pressure makes pancreatic tumors hard to treat

Crafting a better T cell for immunotherapy

10 Fred Hutchinson Cancer Center

Immunotherapy for pancreatic cancer boosts survival more than 75 percent in mice, study finds

Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer

Hutch News Fred Hutchinson Cancer Center

Hutch News Fred Hutchinson Cancer Center

Biomedicines, Free Full-Text

Mielcarek study may change the practice of blood stem-cell transplantation

Hutch News Fred Hutchinson Cancer Center

Hutch News Fred Hutchinson Cancer Center

Deeper insights into long-term survival heterogeneity of

Experimental Drug Enhances Immunotherapy in Mouse Model of Pancreatic Cancer